Artrya Ltd Logo - medical devices

Artrya Ltd

medical devices
China's Best One-Stop Medical Equipment Provider
About

Artrya Ltd is an Australian medical technology company based in West Perth, specializing in artificial intelligence solutions for cardiovascular healthcare. Founded in 2018, Artrya focuses on developing AI-driven platforms that enhance the detection, diagnosis, and management of coronary artery disease (CAD), a major cause of heart attacks. The company's flagship product, Salix, is a cloud-based software suite that automates the analysis of coronary computed tomography angiography (CCTA) scans. Salix helps clinicians identify and characterize arterial plaque, improving the efficiency and accuracy of CAD assessments. This technology supports healthcare providers, particularly clinics treating patients with chest pain, by offering actionable insights into arterial health and facilitating timely interventions. Artrya collaborates with healthcare delivery systems globally to set new standards in cardiac diagnostics. Their software is registered on the Australian Register of Therapeutic Goods, ensuring compliance with medical device regulations. Key executives include Co-Founder and CEO John Konstantopoulos, Executive Chair Bernard William Ridgeway, and Chief Scientific Officer Prof. Girish Dwivedi.

Technologies
Salesforce Route 53 Outlook Pardot Zendesk Netlify Sophos Hubspot Google Font API WordPress.org Google Tag Manager Mobile Friendly Nginx Typekit Remote
Keywords
medical equipment manufacturing deep learning in cardiology healthtech innovation ai-supported cardiac reporting healthcare equipment & supplies predictive analytics in cardiology preventative cardiology coronary artery plaque characterization cardiology ai for emergency cardiac assessment medical devices medical equipment and supplies manufacturing ai-driven healthcare medical image segmentation ai in medical diagnostics personalized treatment support clinical decision support coronary artery visualization tools healthcare technology ai-based diagnostic software high prognostic value features b2b machine learning real-time coronary analysis automated vessel wall segmentation ai-powered medical devices coronary plaque analysis healthcare automation cardiovascular risk stratification ccta image analysis
Company Information
  • Employees 49
  • Founded 2018
  • Annual Revenue $18000
  • Total Funding $55000000
Location

88 Broadway, Perth, Western Australia, Australia, 6009

Related Companies
Companies in the same industry